Related Experiment Video
Updated: Feb 15, 2026

Author Spotlight: Standardizing and Improving the Extraction and Purification of Extracellular Vesicles from Human ADSCs
Published on: May 3, 2024
Mesenchymal stem cell-derived extracellular vesicles attenuate influenza virus-induced acute lung injury in a pig
Mahesh Khatri1, Levi Arthur Richardson2, Tea Meulia3
1Food Animal Health Research Program, Ohio Agricultural Research and Development Center, The Ohio State University, 1680 Madison Avenue, Wooster, OH, 44691, USA. khatri.14@osu.edu.
Background:
Mesenchymal stem (stromal) cells (MSCs) mediate their immunoregulatory and tissue repair functions by secreting paracrine factors, including extracellular vesicles (EVs). In several animal models of human diseases, MSC-EVs mimic the beneficial effects of MSCs. Influenza viruses cause annual outbreaks of acute respiratory illness resulting in significant mortality and morbidity. Influenza viruses constantly evolve, thus generating drug-resistant strains and rendering current vaccines less effective against the newly generated strains. Therefore, new therapies that can control virus replication and the inflammatory response of the host are needed. The objective of this study was to examine if MSC-EV treatment can attenuate influenza virus-induced acute lung injury in a preclinical model.
Methods:
We isolated EVs from swine bone marrow-derived MSCs. Morphology of MSC-EVs was determined by electron microscopy and expression of mesenchymal markers was examined by flow cytometry. Next, we examined the anti-influenza activity of MSC-EVs in vitro in lung epithelial cells and anti-viral and immunomodulatory properties in vivo in a pig model of influenza virus.
Results:
MSC-EVs were isolated from MSC-conditioned medium by ultracentrifugation. MSC-EVs were round-shaped and, similarly to MSCs, expressed mesenchymal markers and lacked the expression of swine leukocyte antigens I and II. Incubation of PKH-26-labeled EVs with lung epithelial cells revealed that MSC-EVs incorporated into the epithelial cells. Next, we examined the anti-influenza and anti-inflammatory properties of MSC-EVs. MSC-EVs inhibited the hemagglutination activity of avian, swine, and human influenza viruses at concentrations of 1.25-5 μg/ml. MSC-EVs inhibited influenza virus replication and virus-induced apoptosis in lung epithelial cells. The anti-influenza activity of MSC-EVs was due to transfer of RNAs from EVs to epithelial cells since pre-incubation of MSC-EVs with RNase enzyme abrogated the anti-influenza activity of MSC-EVs. In a pig model of influenza virus, intratracheal administration of MSC-EVs 12 h after influenza virus infection significantly reduced virus shedding in the nasal swabs, influenza virus replication in the lungs, and virus-induced production of proinflammatory cytokines in the lungs of influenza-infected pigs. The histopathological findings revealed that MSC-EVs alleviated influenza virus-induced lung lesions in pigs.
Conclusions:
Our data demonstrated in a relevant preclinical large animal model of influenza virus that MSC-EVs possessed anti-influenza and anti-inflammatory properties and that EVs may be used as cell-free therapy for influenza in humans.
Insights
Mesenchymal stem cell-derived extracellular vesicles (EVs) show potent anti-influenza and anti-inflammatory effects. This preclinical study suggests MSC-EVs could be a novel cell-free therapy for influenza treatment.
Area of Science:
- Regenerative Medicine
- Virology
- Immunology
Background:
- Mesenchymal stem cells (MSCs) exert therapeutic effects via secreted factors, including extracellular vesicles (EVs).
- MSC-EVs replicate MSC benefits in preclinical models, offering potential as cell-free therapies.
- Influenza viruses pose a significant global health threat due to constant evolution and drug resistance, necessitating novel therapeutic strategies.
Purpose of the Study:
- To investigate the efficacy of MSC-EV treatment in mitigating influenza virus-induced acute lung injury.
- To evaluate the anti-viral and immunomodulatory properties of MSC-EVs in a preclinical influenza model.
Main Methods:
- Extracellular vesicles (EVs) were isolated from swine bone marrow-derived MSCs.
- MSC-EVs characterized via electron microscopy and flow cytometry for mesenchymal markers.
- In vitro anti-influenza activity assessed in lung epithelial cells; in vivo efficacy evaluated in a pig influenza model.
Main Results:
- MSC-EVs inhibited hemagglutination and replication of diverse influenza strains in vitro.
- EVs were incorporated into lung epithelial cells, delivering RNA to confer anti-viral effects.
- In pigs, MSC-EVs reduced viral shedding, lung replication, pro-inflammatory cytokine production, and lung lesions.
Conclusions:
- MSC-derived extracellular vesicles demonstrate significant anti-influenza and anti-inflammatory capabilities.
- These findings support the potential of MSC-EVs as a cell-free therapeutic approach for influenza infections in humans.
More Related Videos
11:15A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
Published on: May 6, 2018
09:10A Simple Benchtop Filtration Method to Isolate Small Extracellular Vesicles from Human Mesenchymal Stem Cells
Published on: June 23, 2022
Related Concept Videos
Mesenchymal Stem Cells
Induced Pluripotent Stem Cells
Induced Pluripotent Stem Cells
Somatic...
Transcription Attenuation in Prokaryotes
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
Acute Kidney Injury I: Introduction
Acute Kidney Injury II: Pathophysiology